These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2976362)

  • 21. Feasibility of targeted drug delivery to selective areas of the retina.
    Ogura Y; Guran T; Shahidi M; Mori MT; Zeimer RC
    Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2351-6. PubMed ID: 2071345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes.
    Do carmo A; Ramos P; Reis A; Proença R; Cunha-vaz JG
    Exp Eye Res; 1998 Nov; 67(5):569-75. PubMed ID: 9878219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The protective effect of human umbilical cord mesenchymal stem cells-induced neural stem cells in the vitreous on the blood-retinal barrier in diabetic rats].
    Dong M; Zhang W; Chen S; Wang JM; Duan HT; Kong JH; Wang YX; Bi X; Song J
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):53-58. PubMed ID: 28162200
    [No Abstract]   [Full Text] [Related]  

  • 24. Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats.
    Koevary SB; Nussey J; Lake S
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):797-804. PubMed ID: 11867601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of aminoguanidine on the blood-retinal barrier in streptozocin-induced diabetic rats.
    Cho HK; Kozu H; Peyman GA; Parry GJ; Khoobehi B
    Ophthalmic Surg; 1991 Jan; 22(1):44-7. PubMed ID: 1826545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes.
    Hollis TM; Gardner TW; Vergis GJ; Kirbo BJ; Butler C; Dull RO; Campos MJ; Enea NA
    J Diabet Complications; 1988; 2(1):47-9. PubMed ID: 2898479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2003 Jan; 458(3):283-9. PubMed ID: 12504784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP; Jones CW; Rusin MM
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of diabetes on transscleral delivery of celecoxib.
    Cheruvu NP; Amrite AC; Kompella UB
    Pharm Res; 2009 Feb; 26(2):404-14. PubMed ID: 18987961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood-retinal barrier breakdown.
    Kim J; Kim CS; Lee YM; Sohn E; Jo K; Kim JS
    Int J Food Sci Nutr; 2015 Mar; 66(2):236-42. PubMed ID: 25582181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of tert-butylhydroquinone on the islets function and expression of HO-1 and VEGF in retina of type 2 diabetic rats].
    Zhang S; Tian M; Li J; Han P; Huang Q; Lyu H
    Zhonghua Yan Ke Za Zhi; 2016 May; 52(5):373-81. PubMed ID: 27220712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats.
    Pugliese G; Tilton RG; Speedy A; Chang K; Santarelli E; Province MA; Eades D; Sherman WR; Williamson JR
    Diabetologia; 1989 Dec; 32(12):845-57. PubMed ID: 2533117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats.
    Desjardins DM; Yates PW; Dahrouj M; Liu Y; Crosson CE; Ablonczy Z
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2706-13. PubMed ID: 27191823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.
    Antonetti DA; Barber AJ; Khin S; Lieth E; Tarbell JM; Gardner TW
    Diabetes; 1998 Dec; 47(12):1953-9. PubMed ID: 9836530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo tyrosine hydroxylation in the diabetic rat retina: effect of tyrosine administration.
    Fernstrom MH; Volk EA; Fernstrom JD
    Brain Res; 1984 Apr; 298(1):167-70. PubMed ID: 6144358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid.
    Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy.
    Chang YH; Chen PL; Tai MC; Chen CH; Lu DW; Chen JT
    Clin Exp Ophthalmol; 2006 Aug; 34(6):584-9. PubMed ID: 16925707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.